Home
>
National Drug Code (NDC)
>
Nadolol and Bendroflumethiazide
Nadolol and Bendroflumethiazide - 0115-5322-02 - (NADOLOL and BENDROFLUMETHIAZIDE)
Drug Information of Nadolol and Bendroflumethiazide
| Product NDC: | 0115-5322 |
| Proprietary Name: | Nadolol and Bendroflumethiazide |
| Non Proprietary Name: | NADOLOL and BENDROFLUMETHIAZIDE |
| Active Ingredient(s): | 5; 80 mg/1; mg/1 & nbsp; NADOLOL and BENDROFLUMETHIAZIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nadolol and Bendroflumethiazide
| Product NDC: | 0115-5322 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077833 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070401 |
Package Information of Nadolol and Bendroflumethiazide
| Package NDC: | 0115-5322-02 |
| Package Description: | 500 TABLET in 1 BOTTLE (0115-5322-02) |
NDC Information of Nadolol and Bendroflumethiazide
| NDC Code | 0115-5322-02 |
| Proprietary Name | Nadolol and Bendroflumethiazide |
| Package Description | 500 TABLET in 1 BOTTLE (0115-5322-02) |
| Product NDC | 0115-5322 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | NADOLOL and BENDROFLUMETHIAZIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20070401 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories, Inc. |
| Substance Name | BENDROFLUMETHIAZIDE; NADOLOL |
| Strength Number | 5; 80 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
